How much does a box of Enasidenib cost in 2025?

Enasidenib (Enasidenib) is an oral small molecule drug mainly used to treat patients with acute myeloid leukemia (AML), especially those with IDH2 gene mutations. Ensidipine changes tumor cell metabolism by selectively inhibiting isocitrate dehydrogenase 2 (IDH2), promotes the generation of mature hematopoietic cells, and effectively slows down tumor progression. Clinical studies have shown that ensidipine has significant efficacy in the treatment of relapsed or refractory AML and can improve the overall remission rate and survival of patients.

Although ensidipine has significant clinical effects, many patients face financial burden due to its high price. In regions such as Europe and the United States, the price of the original drug of ensidipine is generally high. For example, a package of 50mg*30 tablets may cost close to more than 30,000 US dollars. This is undoubtedly a huge challenge for many patients who cannot afford this cost. However, as drug patents gradually expire, some generic drugs have appeared on the market, providing patients with more choices. For example, the price of generic drugs produced by Lao pharmaceutical factories in 50mg*30 tablets is about more than 2,000 yuan. Although they are still affected by exchange rate fluctuations, compared with original drugs, the economic burden is significantly reduced. The ingredients of these generic drugs are basically the same as those of the original drugs, which can guarantee the therapeutic effect to a certain extent.

It is worth noting that during treatment with ensidipine, doctors will regularly monitor the patient's blood routine, liver and kidney function, and other related indicators to evaluate the efficacy of the drug and detect any potential side effects in a timely manner. Common side effects include nausea, vomiting, fatigue and abnormal liver function. Doctors will make corresponding management and adjustments based on the patient's specific situation.

Reference materials:https://medlineplus.gov/druginfo/meds/a617040.html